Cytokine release syndrome

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
CAR-T cell therapy 1 substance
Phase I/II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase I/II

1 trial
  • Universitaetsklinikum Wuerzburg AöR Academic
    DASATINIB; IDECABTAGENE VICLEUCEL
    2023-507537-16-00 1 country n=55 Orphan
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Universitaetsklinikum Wuerzburg AöR Academic 1 Phase I/II 0
← All indication landscapes